These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3593629)

  • 1. Non-bioequivalence of sublingual nifedipine.
    Rietbrock N; Kausch M; Engelhardt M; Woodcock BG
    Br J Clin Pharmacol; 1987 May; 23(5):589-90. PubMed ID: 3593629
    [No Abstract]   [Full Text] [Related]  

  • 2. Kinetics and dynamics of nifedipine after oral and sublingual doses.
    McAllister RG
    Am J Med; 1986 Dec; 81(6A):2-5. PubMed ID: 3799661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Bioavailability of new nifedipine preparations in man. 2. Bioequivalence of nifedipine in the form of soft gelatin capsules].
    Dahmen W; Pabst G; Molz KH; Lutz D; Jaeger H
    Arzneimittelforschung; 1985; 35(12):1842-4. PubMed ID: 4096742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of two commercial oral nifedipine products.
    Shaheen O; Zmeili S; al-Qussuois Y; Arafat T; Mouti H
    Int J Clin Pharmacol Ther Toxicol; 1991 Sep; 29(9):337-41. PubMed ID: 1937993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study on the bioequivalence of an oral nifedipine formulation and a sustained release reference preparation after single dose and repeated doses.
    Tröger U; Martens J; Meyer FP; Hoffmann A; Terhaag B
    Arzneimittelforschung; 1995 Dec; 45(12):1266-70. PubMed ID: 8595082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence and metabolism of nitrendipine administered orally to healthy volunteers.
    Kann J; Krol GJ; Raemsch KD; Burkholder DE; Levitt MJ
    J Cardiovasc Pharmacol; 1984; 6 Suppl 7():S968-73. PubMed ID: 6085386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The bioequivalence of two nifedipine fluid capsules].
    Thürmann P; Bacracheva N
    Arzneimittelforschung; 1989 Dec; 39(12):1597-9. PubMed ID: 2624612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of hypertensive emergencies with sublingual nifedipine].
    Lacchè A; Basaglia P
    Minerva Cardioangiol; 1986 Oct; 34(10):619-24. PubMed ID: 3808329
    [No Abstract]   [Full Text] [Related]  

  • 9. Therapeutic Differences in 24-h Ambulatory Blood Pressures in Patients Switched Between Bioequivalent Nifedipine Osmotic Systems With Differing Delivery Technologies.
    Pollak PT; Herman RJ; Feldman RD
    Clin Transl Sci; 2017 May; 10(3):217-224. PubMed ID: 28233944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A model study of bioequivalence of dissolved nifedipine from soft gelatin capsules].
    Menke G; Kausch M; Rietbrock N
    Arzneimittelforschung; 1988 Feb; 38(2):300-4. PubMed ID: 3370080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and pharmacokinetics of nifedipine administered by different routes in healthy volunteers.
    Palma-Aguirre JA; Rosas-Alcázar G; Rodríguez JM; León-Urrea F; Montoya-Cabrera MA
    Arch Invest Med (Mex); 1989; 20(2):129-35. PubMed ID: 2604495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The bioequivalence of two different batches of two nifedipine controlled-release preparations with deficient batch conformity in in vitro liberation studies].
    Theiss U; Gebhardt E; Müller J
    Arzneimittelforschung; 1992 May; 42(5):629-32. PubMed ID: 1530675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration.
    Kleinbloesem CH; van Harten J; Wilson JP; Danhof M; van Brummelen P; Breimer DD
    Clin Pharmacol Ther; 1986 Jul; 40(1):21-8. PubMed ID: 3720176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of sublingual verapamil in patients with severe essential hypertension: comparison with sublingual nifedipine.
    Al-Waili NS; Hasan NA
    Eur J Med Res; 1999 May; 4(5):193-8. PubMed ID: 10336409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study of the acute antihypertensive effect of Adalat capsules and Corinfar dragées, two different nifedipine preparations.
    Kiss I; Farsang C
    Cor Vasa; 1988; 30(2):105-9. PubMed ID: 3391034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical pharmacokinetics of calcium ion antagonists.
    Eichelbaum M
    Clin Invest Med; 1980; 3(1-2):13-7. PubMed ID: 7471537
    [No Abstract]   [Full Text] [Related]  

  • 17. Nifedipine serum concentrations following sublingual and oral doses.
    Brown GR; Fraser DG; Castile JA; Gaudreault P; Platt DR; Friedman PA
    Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):283-6. PubMed ID: 3733277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nifedipine, a new antihypertensive with rapid action.
    Guazzi M; Olivari MT; Polese A; Fiorentini C; Magrini F; Moruzzi P
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):528-32. PubMed ID: 913018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hypertensive crisis: comparative study of oral captopril, sublingual captopril and sublingual nifedipine].
    Martínez Amenós A; Carratalà J; Pintó X; Santaló M; Tamayo C; Pujol M
    Med Clin (Barc); 1987 Jun; 89(2):59-61. PubMed ID: 3302561
    [No Abstract]   [Full Text] [Related]  

  • 20. Beneficial effects of sublingual nifedipine in patients with ischemic heart disease and depressed left ventricular function.
    Losardo AA; Klein NA; Beer N; Strom JA; Wexler JP; Sonnenblick EH; Frishman WH
    Angiology; 1982 Dec; 33(12):811-7. PubMed ID: 7181173
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.